144 ·Filed Aug 26, 2026

PGEN

PRECIGEN, INC.
NEUTRAL
Impact 3/10
Horizondays Processed1mo ago SEC0001958244-26-000558
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine diversification sale by a director, not a CEO/CFO, and the dollar amount is small relative to market cap. The strong institutional accumulation and bullish analyst consensus suggest no fundamental concern. Monitor for any Form 4 filings confirming execution, but no immediate trading action is warranted.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
PGEN ▲ +7.09% at T+20d
NEUTRAL call ✓ call won +7.09% · α vs SPY +7.60% · entry $7.19 → $7.70
Next anchor: T+60d in 7w
Latest observation: T+24 +4.34% FF3 residual α
Entry anchored
Aug 26, 04:42 PM ET
via 1-min bar
T+1d
-3.34%
call -3.34% · α -3.11%
$6.95
settled 5w ago
T+5d
-0.70%
call -0.70% · α -0.96%
$7.14
settled 4w ago
T+20d
+7.09%
call +7.09% · α +7.60%
$7.70
settled 8d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Director Jeffrey Kindler filed a Form 144 to sell 185,000 shares of Precigen (PGEN) at an estimated aggregate value of $1,372,700. The shares were acquired through restricted stock unit vestings from 2023 to 2026. While the sale is modest relative to the company's $2.6B market cap, it comes amid a period of heavy institutional accumulation and a 78% bullish analyst consensus, making the timing notable but not alarming for a director-level diversification trade.

Key Facts

  • Director Jeffrey Kindler filed Form 144 to sell 185,000 shares of Precigen (PGEN).
  • Estimated aggregate sale value is $1,372,700.
  • Shares were acquired via restricted stock unit vestings on 03/09/2023, 03/09/2024, 03/13/2025, 03/13/2026, and 03/10/2026.
  • The sale is being executed through Goldman Sachs & Co. LLC.
  • PGEN has a market cap of $2.6B and 78% analyst bullish consensus (7 Buy/Strong Buy, 2 Hold).
  • Recent insider activity (30d) shows 2 sells totaling $709K, and this filing adds a third.
  • Institutional 13F data shows strong accumulation: 4 funds doubled positions, 11 added, only 3 trimmed.

Financial Impact

Director selling 185,000 shares worth ~$1.37M, representing approximately 0.05% of market cap

dilutioninsider ownership

Risk Factors

  • Insider selling could signal reduced conviction if followed by additional director sales
  • Form 144 is an intent to sell — actual sale may not occur, but the filing itself signals the insider considered selling

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000558
Document: 0001958244-26-000558-index.html0001958244-26-000558
Document: 0001958244-26-000558.txt0001958244-26-000558
12 reports for PGEN
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +52.17%May 13, 2026
Filters
Rows
Reports for PGEN — sortable, filterable
TypeNow
Aug 29, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.93 $7.94▲ +14.57%▲ +14.51%$8.30 (+19.70%)
Aug 26, 2026
5w ago
144
NEUTRAL ★ 3/10
$7.19 $7.70▲ +7.09%▲ +7.60%$8.30 (+15.37%)
Aug 25, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$7.42 $7.70▼ −3.77%▼ −3.55%$8.30 (−11.79%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$7.42 $7.70▲ +3.77%▲ +3.55%$8.30 (+11.79%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$7.00 $6.87▼ −1.86%▼ −0.94%$8.30 (+18.50%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.53 $6.86▲ +5.05%▲ +6.29%$8.30 (+27.03%)
Jul 1, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$5.64 $5.94▼ −5.32%▼ −5.73%$8.30 (−47.07%)
Jun 24, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$5.52 $5.54▲ +0.36%▼ −0.17%$8.30 (+50.27%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.86 $5.25▲ +36.01%▲ +37.58%$8.30 (+114.90%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.86 $5.25▲ +36.01%▲ +37.58%$8.30 (+114.90%)
Showing 10 of 12

US Market Status

Market Open — Closes in 3h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access